• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Italy's AIFA approves using different vaccine for second dose after AstraZeneca jab

firstwordpharmaJune 15, 2021

Tag: AstraZeneca , COVID-19 , Vaccine

Italy's medicine agency AIFA said Italians under the age of 60 who received a first dose of the AstraZeneca COVID-19 vaccine Vaxzevria can be given a different vaccine when they get their second dose, as reported in Yahoo!News.

Italy's AIFA approves using different vaccine for second dose after AstraZeneca jab

Last week, Italy restricted the use of Vaxzevria to people over the age of 60, after a teenager who had received the shot died from a rare form of blood clotting.

"Based on clinical studies published in the last few weeks, AIFA's scientific committee has decided to approve the vaccine mix," AIFA said in a statement, adding vaccines developed by Pfizer and Moderna could be administered to people who first got an AstraZeneca jab.

Previous:Weight-Loss Surgeries Used Least in U.S. States That Need Them Most

Next:Good News, Bad News From Alzheimer's Vaccine Trial

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Italy's AIFA approves using different vaccine for second dose after AstraZeneca jab | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

B11 100ml amber plastic vaccine bottle

B11 100ml amber plastic vaccine bottle
Polyvalent Pneumococcal Polysaccharide Vaccine

Polyvalent Pneumococcal Polysaccharide Vaccine
2019-nCoV Vaccine(Vero Cells),Inactivated

2019-nCoV Vaccine(Vero Cells),Inactivated
Haemophilus Influenza Type B Conjugate Vaccine

Haemophilus Influenza Type B Conjugate Vaccine
Influenza Vaccine(Split Virion),Inactivated

Influenza Vaccine(Split Virion),Inactivated
500ml pp vaccine bottle manufacturer

500ml pp vaccine bottle manufacturer
Group ACYW135 Meningococcal Polysaccharide Vaccine

Group ACYW135 Meningococcal Polysaccharide Vaccine
Swine Vaccine Series

Swine Vaccine Series
Ruminant Vaccine Series

Ruminant Vaccine Series
Animal Vaccine Filling Line

Animal Vaccine Filling Line

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service